Smarter Studies
We work to deliver swifter and more effective translation of scientific research into patient benefits
Global Impact
We are at the forefront of resolving internationally important questions
Better Health
Our research helps to improve healthcare around the world
The MRC Clinical Trials Unit at UCL became the UCL Innovative Clinical Trials Unit in April 2026. The Innovative Clinical Trials Unit is continuing the mission of smarter studies and global impact, leading to better health.
Latest News
Using two immunotherapy drugs together benefits people with kidney cancer
New results from the RAMPART trial found that giving durvalumab alone did not help prevent kidney cancer from coming back after surgery compared to active monitoring.
02 Jun
A new trial for people living with relapsing-remitting multiple sclerosis launches in the UK
The REFINE-MS trial will evaluate if people living with relapsing-remitting MS can take treatment less often while keeping their disease activity under control.
01 Jun
AI tool for radiotherapy can support the global effort to eliminate cervical cancer
An AI technology is effective at planning the delivery of life-saving radiotherapy for cervical cancer and prostate cancer.
18 May
A routine blood test offers new insight into survival in advanced prostate cancer
Analysis from the STAMPEDE trial shows that combining a PSA blood test with information about cancer burden at diagnosis predicts survival more accurately than PSA levels alone.
30 Apr
In 2024, we celebrated our 25th anniversary. That's 25 years of smarter studies, global impact and better health. '25 at 25' is a series of articles highlighting 25 of our major achievements in that time.
Research Themes
Cancer
Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types
Infections
Major international clinical trials answering questions of global public health significance
Neurodegenerative diseases
New generation of innovative multi-arm multi-stage trials to identify and test new therapeutic treatments in neurodegenerative diseases (NDD)
Methodology
Development of methods with direct impact on the design, conduct and analysis of studies
Other Research & Policy
This section will capture projects outside the current QQR themes
